Mesoblast Limited (MSB) Stock Statistics & Valuation Metrics

Mesoblast Limited has a market cap or net worth of AUD 2.64B. The enterprise value is AUD 3.52B.

Market Cap

AUD 2.64B

Enterprise Value

AUD 3.52B

Mesoblast Limited has 1,301,298,100 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

1,301,298,100

Owned by Insiders

29.23%

Owned by Institutions

5.68%

Mesoblast Limited’s return on equity (ROE) is -0.10 and return on invested capital (ROIC) is -7.43%.

Return on Equity (ROE)

-0.10

Return on Assets (ROA)

-0.08

Return on Invested Capital (ROIC)

-7.43%

Return on Capital Employed (ROCE)

-0.08

Revenue Per Employee

1.14M

Profits Per Employee

-544.10K

Employee Count

108

Asset Turnover

0.16

Inventory Turnover

0.70

The current PE Ratio of Mesoblast Limited is -32.06. Mesoblast Limited’s PEG ratio is -0.46.

PE Ratio

-32.06

PS Ratio

15.03

PB Ratio

3.25

Price to FCF

-57.87

Price to Operating Cash Flow

-59.46

PEG Ratio

-0.46

In the last 12 months, Mesoblast Limited had revenue of 122.89M and earned -58.76M in profits. Earnings per share was -0.05.

Revenue

122.89M

Gross Profit

103.34M

Operating Income

-52.40M

Pretax Income

-58.14M

Net Income

-58.76M

EBITDA

-43.94M

Earnings Per Share (EPS)

-0.05

In the last 12 months, operating cash flow was -43.83M and capital expenditures -898,000, giving a free cash flow of -44.73M billion.

Operating Cash Flow

-43.83M

Free Cash Flow

-44.73M

Free Cash Flow per Share

-0.02

Mesoblast Limited pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-1.74%

Earnings Yield

-3.14%

Beta

1.76

52-Week Price Change

-11.35%

50-Day Moving Average

2.08

200-Day Moving Average

2.16

Relative Strength Index (RSI)

49.44

Average Volume (3m)

3.15M

Mesoblast Limited upcoming earnings date is Mar 04, 2027, TBA (Not Confirmed).

Last Earnings Date

Feb 27, 2026

Next Earnings Date

Mar 04, 2027

Ex-Dividend Date

―

Mesoblast Limited as a current ratio of 2.43, with Debt / Equity ratio of 22.40%

Current Ratio

2.43

Quick Ratio

2.09

Debt to Market Cap

0.07

Net Debt to EBITDA

-1.82

Interest Coverage Ratio

-2.15

In the past 12 months, Mesoblast Limited has paid 626.46K in taxes.

Income Tax

626.46K

Effective Tax Rate

-0.01

Mesoblast Limited EV to EBITDA ratio is -42.93, with an EV/FCF ratio of -59.98.

EV to Sales

15.58

EV to EBITDA

-42.93

EV to Free Cash Flow

-59.98

EV to Operating Cash Flow

-61.67

Mesoblast Limited has AUD 47.39M in cash and marketable securities with AUD 127.33M in debt, giving a net cash position of -AUD 79.94M billion.

Cash & Marketable Securities

AUD 47.39M

Total Debt

AUD 127.33M

Net Cash

-AUD 79.94M

Net Cash Per Share

-AUD 0.06

Tangible Book Value Per Share

AUD 0.00

Gross margin is 78.30%, with operating margin of -96.11%, and net profit margin of -46.79%.

Gross Margin

78.30%

Operating Margin

-96.11%

Pretax Margin

-46.29%

Net Profit Margin

-46.79%

EBITDA Margin

-36.30%

EBIT Margin

-41.70%

The average price target for Mesoblast Limited is AUD 3.51, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target

AUD 3.51

Price Target Upside

72.74% Upside

Analyst Consensus

Strong Buy

Analyst Count

3

Revenue Growth Forecast

555.67%

EPS Growth Forecast

49.08%

Smart Score

7

AI Score

56